Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Unsolved mystery of Fas: mononuclear cells may have trouble dying in patients with Sjogren's syndrome

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F23%3A10466207" target="_blank" >RIV/00179906:_____/23:10466207 - isvavai.cz</a>

  • Nalezeny alternativní kódy

    RIV/44555601:13440/23:43897743 RIV/00216208:11150/23:10466207

  • Výsledek na webu

    <a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=Nj4N7HCFJ5" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=Nj4N7HCFJ5</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1186/s12865-023-00544-5" target="_blank" >10.1186/s12865-023-00544-5</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Unsolved mystery of Fas: mononuclear cells may have trouble dying in patients with Sjogren's syndrome

  • Popis výsledku v původním jazyce

    Background: Patients with Sjogren&apos;s syndrome, like other patients with autoimmune disorders, display dysregulation in the function of their immune system. Fas and Fas Ligand (FasL) are among the dysregulated proteins. Methods: We studied Fas and FasL on IL-2R alpha(+) cells and in serum of patients with Sjogren&apos;s syndrome (n = 16) and healthy individuals (n = 16); both from same ethnic and geographical background. We used flow cytometry and enzyme-linked immunosorbent for this purpose. We also measured the expression of Bcl-2 and Bax by reverse transcription quantitative real-time PCR (RT-qPCR) and percentage of apoptotic and dead cells using Annexin V and 7-AAD staining in lymphocytes. Results: FasL was increased in patients&apos; T and B cells while Fas was increased in patients&apos; monocytes, T and B cells. No signs of increased apoptosis were found. sFas and sFasL in patients&apos; serum were increased, although the increase in sFasL was not significant. We suspect an effect of non-steroidal anti-inflammatory therapy on B cells, explaining the decrease of the percentage Fas(+) B cells found within our samples. In healthy individuals, there was a noticeable pattern in the expression of FasL which mutually correlated to populations of mononuclear cells; this correlation was absent in the patients with Sjogren&apos;s syndrome. Conclusion: sMononuclear cells expressing IL-2R alpha(+) had upregulated Fas in Sjogren&apos;s syndrome. However, the rate of apoptosis based on Annexin V staining and the Bcl-2/Bax expression was not observed in mononuclear cells. We suspect a functional role of abnormal levels of Fas and FasL which has not been cleared yet.

  • Název v anglickém jazyce

    Unsolved mystery of Fas: mononuclear cells may have trouble dying in patients with Sjogren's syndrome

  • Popis výsledku anglicky

    Background: Patients with Sjogren&apos;s syndrome, like other patients with autoimmune disorders, display dysregulation in the function of their immune system. Fas and Fas Ligand (FasL) are among the dysregulated proteins. Methods: We studied Fas and FasL on IL-2R alpha(+) cells and in serum of patients with Sjogren&apos;s syndrome (n = 16) and healthy individuals (n = 16); both from same ethnic and geographical background. We used flow cytometry and enzyme-linked immunosorbent for this purpose. We also measured the expression of Bcl-2 and Bax by reverse transcription quantitative real-time PCR (RT-qPCR) and percentage of apoptotic and dead cells using Annexin V and 7-AAD staining in lymphocytes. Results: FasL was increased in patients&apos; T and B cells while Fas was increased in patients&apos; monocytes, T and B cells. No signs of increased apoptosis were found. sFas and sFasL in patients&apos; serum were increased, although the increase in sFasL was not significant. We suspect an effect of non-steroidal anti-inflammatory therapy on B cells, explaining the decrease of the percentage Fas(+) B cells found within our samples. In healthy individuals, there was a noticeable pattern in the expression of FasL which mutually correlated to populations of mononuclear cells; this correlation was absent in the patients with Sjogren&apos;s syndrome. Conclusion: sMononuclear cells expressing IL-2R alpha(+) had upregulated Fas in Sjogren&apos;s syndrome. However, the rate of apoptosis based on Annexin V staining and the Bcl-2/Bax expression was not observed in mononuclear cells. We suspect a functional role of abnormal levels of Fas and FasL which has not been cleared yet.

Klasifikace

  • Druh

    J<sub>imp</sub> - Článek v periodiku v databázi Web of Science

  • CEP obor

  • OECD FORD obor

    30208 - Dentistry, oral surgery and medicine

Návaznosti výsledku

  • Projekt

  • Návaznosti

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Ostatní

  • Rok uplatnění

    2023

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    BMC Immunology

  • ISSN

    1471-2172

  • e-ISSN

    1471-2172

  • Svazek periodika

    24

  • Číslo periodika v rámci svazku

    1

  • Stát vydavatele periodika

    GB - Spojené království Velké Británie a Severního Irska

  • Počet stran výsledku

    15

  • Strana od-do

    12

  • Kód UT WoS článku

    001011253300001

  • EID výsledku v databázi Scopus

    2-s2.0-85162754222